Market revenue in 2023 | USD 71.6 million |
Market revenue in 2030 | USD 82.8 million |
Growth rate | 2.1% (CAGR from 2023 to 2030) |
Largest segment | Cannabis/marijuana |
Fastest growing segment | Cannabis/Marijuana |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD, Other Drug Types |
Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, Clinical Reference Laboratory, Cordant Health Solutions, ZeOmega, Psychemedics Corp, Millennium HealthCare Inc, Mayo Clinic, Precision Diagnostics, LGC Group, Labcorp Drug Development, Legacy Medical, Drugscan, USDTL |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug of abuse testing services market will help companies and investors design strategic landscapes.
Cannabis/marijuana was the largest segment with a revenue share of 24.3% in 2023. Horizon Databook has segmented the Brazil drug of abuse testing services market based on alcohol, cannabis/marijuana, cocaine, opioids, amphetamine & methamphetamine, lsd, other drug types covering the revenue growth of each sub-segment from 2018 to 2030.
High prevalence of drug abuse in Brazil is anticipated to be a major factor boosting the demand for testing services in the region. According to a study published by the Brazilian Journal of Psychiatry, in February 2018, Brazil was the biggest consumer of crack-cocaine globally, with about 1.7 million regular users.
As per the new contract, Toxicologia Pardini and Sansão were designated as distributors of Psychemedics’ hair drug testing services in Brazil. In October 2019, Omega Laboratories obtained DENATRAN accreditation for its São Paulo facility, Omega Global Laboratory Services Do Brasil.
With this, the company expanded its operations in Brazil. However, conducting alcohol and drug testing at workplaces in Brazil can be complicated from a legal perspective. The presence of unclear laws on workplace testing in the country is anticipated to limit the demand for drug of abuse testing services.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil drug of abuse testing services market , including forecasts for subscribers. This country databook contains high-level insights into Brazil drug of abuse testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account